Takeda Pharmaceuticals USA, Inc

CIK 1716229 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Takeda Pharmaceuticals USA, Inc.

Recent SEC filings

FiledFormAccession number
Dec 9, 202540001395064-25-000172
Jul 6, 202240001395064-22-000121
Dec 9, 202140001395064-21-000248
Dec 7, 202140001395064-21-000246
Nov 29, 202140001395064-21-000238
May 13, 201940001209191-19-029480
May 8, 201930001209191-19-028340
Mar 29, 201830000899243-18-008945
Sep 8, 201730000899243-17-021638